SCHEMBL9911083

SCHEMBL9911083

Clc1cc(Cl)nc([SrH])n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27915759 0.72 ALDH1A1 (0.50)
SCHEMBL218052 0.72
SCHEMBL30150311 0.67 S1PR2 (0.30)
SCHEMBL113085 0.67
SCHEMBL21209622 0.67
SCHEMBL8344188 0.67
SCHEMBL28166855 0.67
SCHEMBL5312316 0.67
SCHEMBL6565504 0.67
SCHEMBL27708177 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 955 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115197201-B Chrysin derivative containing aminopyrimidine ring as well as preparation method and application thereof 九江学院 2023-12-26 CN claimed
CN-115197201-A Chrysin derivative containing aminopyrimidine ring and preparation method and application thereof 九江学院 2022-10-18 CN claimed
CN-113024536-B 5-aminothiazole methanamide compound containing pyrimidine-piperazine ring and preparation method and application thereof 湖南师范大学 2022-05-27 CN claimed
CN-109796448-B Preparation process of dasatinib 山东罗欣药业集团股份有限公司 2022-05-10 CN claimed
CN-113767925-A Bactericidal composition containing captan and cymoxanil and preparation method thereof 毅植农业科技有限公司 2021-12-10 CN claimed
CN-113024536-A 5-aminothiazole methanamide compound containing pyrimidine-piperazine ring and preparation method and application thereof 湖南师范大学 2021-06-25 CN claimed
CN-109678853-B Preparation process of dasatinib 山东罗欣药业集团股份有限公司 2020-09-11 CN claimed
CN-109503568-B Preparation method of dasatinib 山东罗欣药业集团股份有限公司 2020-08-07 CN claimed
CN-109369638-B Preparation process of dasatinib 山东罗欣药业集团股份有限公司 2020-07-07 CN claimed
CN-107043375-B Novel method for preparing dasatinib and intermediate thereof 江苏食品药品职业技术学院 2020-03-20 CN claimed
WO-2015049645-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF DASATINIB ALEMBIC PHARMACEUTICALS LIMITED (IN) 2015-04-09 WO claimed
EP-4308096-B1 HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2026-05-13 EP disclosed
US-20260103464-A1 CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2026-04-16 US disclosed
EP-3901151-B1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2026-04-01 EP disclosed
US-12565511-B2 SOS1 inhibitor containing phosphorus CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2026-03-03 US disclosed
US-4477450-A BRONCHODILATORS RIKER LABORATORIES, INC. (US) 1984-10-16 US disclosed
EP-0121341-A1 Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings RIKER LABORATORIES, INCORPORATED (US) 1984-10-10 EP disclosed
EP-0004173-B1 2,3-DIHYDROIMIDAZO (1,2-C) PYRIMIDINES, THEIR PREPARATION, FORMULATIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS ELI LILLY AND COMPANY (US) 1982-09-22 EP disclosed
EP-0004173-A1 2,3-Dihydroimidazo (1,2-c) pyrimidines, their preparation, formulations containing them and their use as pharmaceuticals ELI LILLY AND COMPANY (US) 1979-09-19 EP disclosed
US-4153695-A VIRICIDES ELI LILLY AND COMPANY (US) 1979-05-08 US disclosed